<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03667690</url>
  </required_header>
  <id_info>
    <org_study_id>CD101.IV.3.05</org_study_id>
    <nct_id>NCT03667690</nct_id>
  </id_info>
  <brief_title>Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis</brief_title>
  <acronym>ReSTORE</acronym>
  <official_title>A Phase 3, Multicenter, Randomized, Double-blind Study of the Efficacy and Safety of Rezafungin for Injection vs. Intravenous Caspofungin Followed by Oral Fluconazole Step Down in the Treatment of Subjects With Candidemia and/or Invasive Candidiasis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cidara Therapeutics Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cidara Therapeutics Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this pivotal study is to determine if intravenous Rezafungin is efficacious&#xD;
      and safe in the treatment of candidemia and/or invasive candidiasis when compared to&#xD;
      caspofungin (followed by optional oral fluconazole).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A Phase 3, multicenter, prospective, randomized, double-blind, efficacy and safety study of&#xD;
      Rezafungin for Injection versus an active comparator regimen of caspofungin followed by&#xD;
      optional oral fluconazole step-down therapy in subjects with candidemia and/or invasive&#xD;
      candidiasis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 12, 2018</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">October 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>All cause mortality (US FDA only)</measure>
    <time_frame>Day 30 (-2 days)</time_frame>
    <description>The number of subjects in each treatment group who are alive and deceased (or with missing data) in the mITT population.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>All cause mortality (US FDA only)</measure>
    <time_frame>Day 30 (-2 days)</time_frame>
    <description>The percentage of subjects in each treatment group who are alive and deceased (or with missing data) in the mITT population.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Global Cure (EU only)</measure>
    <time_frame>Day 14 (±1 day)</time_frame>
    <description>The number of subjects in each treatment group who have a global response of cure (clinical cure as assessed by the Investigator, radiological cure [for qualifying invasive candidiasis subjects at baseline], and mycological eradication, as confirmed by the DRC), failure and indeterminate in the modified Intent to Treat (mITT2) population.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Global Cure (EU only)</measure>
    <time_frame>Day 14 (±1 day)</time_frame>
    <description>The percentage of subjects in each treatment group who have a global response of cure (clinical cure as assessed by the Investigator, radiological cure [for qualifying invasive candidiasis subjects], and mycological eradication, as confirmed by the DRC), failure and indeterminate in the modified Intent to Treat (mITT) population.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Global Cure</measure>
    <time_frame>Day 14 (±1 day)</time_frame>
    <description>The number of subjects in each treatment group who have a global response of cure (clinical cure as assessed by the Investigator, radiological cure [for qualifying invasive candidiasis subjects at baseline], and mycological eradication, as confirmed by the DRC), failure and indeterminate in the mITT population.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Cure</measure>
    <time_frame>Day 5, Day 30 (-2 days), EOT (≤2 days of last dose) and Follow-up (Days 52-59)</time_frame>
    <description>The number of subjects in each treatment group who have a global response of cure (clinical cure as assessed by the Investigator, radiological cure [for qualifying invasive candidiasis subjects at baseline], and mycological eradication, as confirmed by the DRC), failure and indeterminate in the mITT population.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Cure</measure>
    <time_frame>Day 14 (±1 day)</time_frame>
    <description>The percentage of subjects in each treatment group who have a global response of cure (clinical cure as assessed by the Investigator, radiological cure [for qualifying invasive candidiasis subjects at baseline], and mycological eradication, as confirmed by the DRC), failure and indeterminate in the mITT population.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Cure</measure>
    <time_frame>Day 5, Day 30 (-2 days), EOT (≤2 days of last dose) and Follow-up (Days 52-59)</time_frame>
    <description>The percentage of subjects in each treatment group who have a global response of cure (clinical cure as assessed by the Investigator, radiological cure [for qualifying invasive candidiasis subjects at baseline], and mycological eradication, as confirmed by the DRC), failure and indeterminate in the mITT population.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All cause mortality (EU only)</measure>
    <time_frame>Day 30 (-2 days)</time_frame>
    <description>The number of subjects in each treatment group who are alive and deceased (or with missing data) in the mITT population.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All cause mortality (EU only)</measure>
    <time_frame>Day 30 (-2 days)</time_frame>
    <description>The percentage of subjects in each treatment group who are alive and deceased (or with missing data) in the mITT population.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of Global Response (as confirmed by the DRC)</measure>
    <time_frame>Day 5, Day 30 (-2 days), End Of Treatment (≤2 days of last dose) and Follow-up (Days 52-59).</time_frame>
    <description>The number of subjects with a global response of cure, failure, or indeterminate will be presented by treatment group in the mITT population</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of Global Response (as confirmed by the DRC)</measure>
    <time_frame>Day 5, Day 30 (-2 days), End Of Treatment (≤2 days of last dose) and Follow-up (Days 52-59).</time_frame>
    <description>The percentage of subjects with a global response of cure, failure, or indeterminate will be presented by treatment group in the mITT population</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of Mycological Response</measure>
    <time_frame>Day 5, Day 14 (±1 day), Day 30 (-2 days), End Of Treatment (≤2 days of last dose), and Follow-up (Days 52-59).</time_frame>
    <description>The number of subjects with a mycological response of eradication, failure, or indeterminate, by treatment group, in the mITT population</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of Mycological Response</measure>
    <time_frame>Day 5, Day 14 (±1 day), Day 30 (-2 days), End Of Treatment (≤2 days of last dose), and Follow-up (Days 52-59).</time_frame>
    <description>The percentage of subjects with a mycological response of eradication, failure, or indeterminate, by treatment group, in the mITT population</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of Clinical Cure</measure>
    <time_frame>Day 5, Day 14 (±1 day), Day 30 (-2 days), End Of Treatment (≤2 days of last dose), and Follow-up (Days 52-59).</time_frame>
    <description>The number of subjects with a clinical response of cure, failure, or indeterminate, presented by treatment group, in the mITT population</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of Clinical Cure</measure>
    <time_frame>Day 5, Day 14 (±1 day), Day 30 (-2 days), End Of Treatment (≤2 days of last dose), and Follow-up (Days 52-59).</time_frame>
    <description>The percentage of subjects with a clinical response of cure, failure, or indeterminate, presented by treatment group, in the mITT population</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of treatment emergent adverse events [Safety and Tolerability]</measure>
    <time_frame>Day 1 through Follow-up visit (Days 52-59)</time_frame>
    <description>Number of Subjects with Incidence of Treatment Emergent Adverse Events based on clinical chemistry, hematology and urine analysis laboratory test, vital sign, physical exams and ECG abnormalities.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate Pharmacokinetics (Cmax)</measure>
    <time_frame>Day 1; Days 2, 3, 4, or 5 (one sample on one day only); Day 8; Day 14 (for subjects not receiving a Day 15 dose); Day 15 (if applicable) and Day 22 (if applicable)</time_frame>
    <description>Evaluate maximum plasma concentration (Cmax)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate Pharmacokinetics (Time to Cmax [Tmax])</measure>
    <time_frame>Day 1; Days 2, 3, 4, or 5 (one sample on one day only); Day 8; Day 14 (for subjects not receiving a Day 15 dose); Day 15 (if applicable) and Day 22 (if applicable)</time_frame>
    <description>Evaluate Tmax (time to Cmax)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate Pharmacokinetics (AUC)</measure>
    <time_frame>Day 1; Days 2, 3, 4, or 5 (one sample on one day only); Day 8; Day 14 (for subjects not receiving a Day 15 dose); Day 15 (if applicable) and Day 22 (if applicable)</time_frame>
    <description>Evaluate area under the curve (AUC)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of Radiological Cure</measure>
    <time_frame>Day 5, Day 14 (±1 day), Day 30 (-2 days), EOT (≤2 days of last dose), and Follow-up (Days 52-59)</time_frame>
    <description>The number of invasive candidiasis subjects with radiological cure, failure, or indeterminate, presented by treatment group, in the mITT population.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of Radiological Cure</measure>
    <time_frame>Day 5, Day 14 (±1 day), Day 30 (-2 days), EOT (≤2 days of last dose), and Follow-up (Days 52-59)</time_frame>
    <description>The percentage of invasive candidiasis subjects with radiological cure, failure, or indeterminate, presented by treatment group, in the mITT population.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">199</enrollment>
  <condition>Candidemia</condition>
  <condition>Mycoses</condition>
  <condition>Fungal Infection</condition>
  <condition>Invasive Candidiases</condition>
  <arm_group>
    <arm_group_label>Group 1: Rezafungin for Injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects in Rezafungin treatment group will receive a 400 mg loading dose in Week 1, followed by 200 mg once weekly, for a total of 2 to 4 doses.&#xD;
Daily intravenous placebo infusions, when not administered Rezafungin and a daily placebo for oral step-down therapy (first eligibility on Day 4 or later as advised by a site's national/regional/local guidelines) administered every day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2: Caspofungin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects in caspofungin arm will receive a total treatment of ≥14 days beginning with a single caspofungin 70 mg IV loading dose on Day 1 followed by 50 mg IV once daily up to 28 days. After ≥3 days of caspofungin treatment(or the minimum duration of IV therapy advised by the site's national/regional/local guidelines, whichever is greater), subjects may be switched to oral fluconazole if specific parameters are met.&#xD;
If the subject qualifies, then oral step-down therapy of fluconazole (6 mg/kg to the nearest 200 mg) is administered. After switch to oral step down before Day 8, subjects in the caspofungin group will receive IV placebo on Day 8 to preserve the study blind.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rezafungin for Injection</intervention_name>
    <description>Intravenous antifungal therapy</description>
    <arm_group_label>Group 1: Rezafungin for Injection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Caspofungin</intervention_name>
    <description>Intravenous antifungal therapy</description>
    <arm_group_label>Group 2: Caspofungin</arm_group_label>
    <other_name>Cancidas</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fluconazole</intervention_name>
    <description>Oral antifungal therapy</description>
    <arm_group_label>Group 2: Caspofungin</arm_group_label>
    <other_name>generic fluconazole</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>intravenous placebo</intervention_name>
    <description>Normal saline</description>
    <arm_group_label>Group 2: Caspofungin</arm_group_label>
    <other_name>placebo infusion</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>oral placebo</intervention_name>
    <description>Microcrystalline cellulose</description>
    <arm_group_label>Group 1: Rezafungin for Injection</arm_group_label>
    <other_name>encapsulated cellulose</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Willing and able to provide written informed consent. If the subject is unable to&#xD;
             consent for himself/herself, a legally acceptable representative must provide informed&#xD;
             consent on his/her behalf.&#xD;
&#xD;
          2. Males or females ≥18 years of age.&#xD;
&#xD;
          3. Established mycological diagnosis of candidemia and/or invasive candidiasis from a&#xD;
             sample taken ≤4 days (96 hours) before randomization defined as&#xD;
&#xD;
               -  ≥1 blood culture positive for yeast or Candida OR&#xD;
&#xD;
               -  Positive test for Candida from a Sponsor-approved rapid IVD OR&#xD;
&#xD;
               -  Positive gram stain (or other method of direct microscopy) for yeast or positive&#xD;
                  culture for Candida spp. from a specimen obtained from a normally sterile site.&#xD;
&#xD;
          4. Presence of one or more systemic signs attributable to candidemia or invasive&#xD;
             candidiasis appearing from ≤12 hours prior to the qualifying positive culture through&#xD;
             time of randomization.&#xD;
&#xD;
          5. Willing to initiate or continue medical treatment to cure infections, including&#xD;
             receipt of antibiotics and surgical procedures, if required.&#xD;
&#xD;
          6. Female subjects of childbearing potential (all female subjects between 18 years &lt;2&#xD;
             years post-menopausal unless surgically sterile) must agree to and comply with using&#xD;
             one barrier method (e.g., female condom with spermicide) plus one other highly&#xD;
             effective method of birth control, or sexual abstinence while participating in this&#xD;
             study. Male subjects must be vasectomized, abstain from sexual intercourse, or agree&#xD;
             to use barrier contraception, and also agree not to donate sperm while participating&#xD;
             in the study and for 90 days thereafter (and at least 120 days from the last dose of&#xD;
             study drug).&#xD;
&#xD;
          7. For Candidemia only subjects, drawing of a set of blood cultures within 12 hours prior&#xD;
             to randomization in the study. The result of these blood cultures is not required for&#xD;
             inclusion in the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Any of the following forms of invasive candidiasis at baseline:&#xD;
&#xD;
               1. Septic arthritis in a prosthetic joint (septic arthritis in a native joint is&#xD;
                  allowed)&#xD;
&#xD;
               2. Osteomyelitis&#xD;
&#xD;
               3. Endocarditis or myocarditis&#xD;
&#xD;
               4. Meningitis, endophthalmitis, chorioretinitis, or any central nervous system&#xD;
                  infection&#xD;
&#xD;
               5. Chronic disseminated candidiasis&#xD;
&#xD;
               6. Urinary tract candidiasis due to ascending Candida infection secondary to&#xD;
                  obstruction or surgical instrumentation of the urinary tract&#xD;
&#xD;
          2. Received systemic treatment with an antifungal agent at approved doses for treatment&#xD;
             of candidemia for &gt;48 hours (e.g., &gt;2 doses of a once daily antifungal agent or &gt;4&#xD;
             doses of a twice daily antifungal agent) ≤4 days (96 hours) before randomization&#xD;
&#xD;
             a. Exception: Receipt of antifungal therapy to which any Candida spp. isolated in&#xD;
             culture is not susceptible&#xD;
&#xD;
          3. Alanine aminotransferase or aspartate aminotransferase levels &gt;10-fold the upper limit&#xD;
             of normal&#xD;
&#xD;
          4. Severe hepatic impairment in subjects with a history of chronic cirrhosis (Child-Pugh&#xD;
             score &gt;9)&#xD;
&#xD;
          5. Presence of an indwelling vascular catheter or device that cannot be removed or an&#xD;
             abscess that cannot be drained and is likely to be the source of candidemia or&#xD;
             invasive candidiasis&#xD;
&#xD;
          6. Known hypersensitivity to Rezafungin for Injection, caspofungin, any echinocandin, or&#xD;
             to any of their excipients&#xD;
&#xD;
          7. Meets National Cancer Institute Common Terminology Criteria for Adverse Events,&#xD;
             version 5, criteria for ataxia, tremor, motor neuropathy, or sensory neuropathy of&#xD;
             Grade 2 or higher&#xD;
&#xD;
          8. History of severe ataxia, tremor, or neuropathy or a diagnosis of multiple sclerosis&#xD;
             or a movement disorder (including Parkinson's Disease or Huntington's Disease)&#xD;
&#xD;
          9. Planned or ongoing therapy at Screening with a known neurotoxic medication&#xD;
&#xD;
         10. Previous participation in this or any previous rezafungin study&#xD;
&#xD;
         11. Current participation in another interventional treatment trial with an&#xD;
             investigational agent&#xD;
&#xD;
         12. Recent use of an investigational medicinal product within 28 days of the first dose of&#xD;
             study drug or presence of an investigational device at the time of screening.&#xD;
&#xD;
         13. Pregnant or lactating females&#xD;
&#xD;
         14. The Principal Investigator (PI) is of the opinion the subject should not participate&#xD;
             in the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Taylor Sandison, MD, MPH</last_name>
    <role>Study Director</role>
    <affiliation>Cidara Therapeutics Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UC Davis</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Augusta University</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30912</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Henry Ford Health System</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Hospital-Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55902</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Mississippi Medical Center</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington University St. Louis</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mecury Street Medical</name>
      <address>
        <city>Butte</city>
        <state>Montana</state>
        <zip>59701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of North Carolina</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27514</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ID Clinical Research, Ltd.</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Falk Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Reading Hospital and Medical Center</name>
      <address>
        <city>West Reading</city>
        <state>Pennsylvania</state>
        <zip>19611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The University of Texas Health Science Center at San Antonio</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor Scott and White Medical Center</name>
      <address>
        <city>Temple</city>
        <state>Texas</state>
        <zip>76508</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carilion Clinic</name>
      <address>
        <city>Roanoke</city>
        <state>Virginia</state>
        <zip>24014</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alexander Fleming Specialized Medical Institute</name>
      <address>
        <city>Buenos Aires</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cordoba Private Hospital</name>
      <address>
        <city>Córdoba</city>
        <zip>5016</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Allende Sanatorium</name>
      <address>
        <city>Córdoba</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Private Sanatorium</name>
      <address>
        <city>Córdoba</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Italian Hospital of Mendoza</name>
      <address>
        <city>Mendoza</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Westmead Public Hospital</name>
      <address>
        <city>Northmead</city>
        <state>New South Wales</state>
        <zip>2152</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Monash Health</name>
      <address>
        <city>Clayton</city>
        <state>Victoria</state>
        <zip>3168</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peter MacCallum Cancer Centre</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3000</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alfred Health</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3004</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Melbourne Hospital (RMH)</name>
      <address>
        <city>Parkville</city>
        <state>Victoria</state>
        <zip>3052</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brugmann University Hospital Center</name>
      <address>
        <city>Brussels</city>
        <zip>1020</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Erasme Hospital</name>
      <address>
        <city>Brussels</city>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Brussels</name>
      <address>
        <city>Brussels</city>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Luc University Hospital</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospitals Leuven, Campus Gasthuisberg</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Multiprofile Hospital for Active Treatment Puls</name>
      <address>
        <city>Blagoevgrad</city>
        <zip>2700</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Multiprofile Hospital for Active Treatment and Emergency Medicine N.I. Pirogov EAD, Sofia, Clinic of Purulent-Septic Surgery</name>
      <address>
        <city>Sofia</city>
        <zip>1606</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Multiprofile Hospital for Active Treatment and Emergency Medicine N.I. Pirogov EAD</name>
      <address>
        <city>Sofia</city>
        <zip>1606</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Bengbu Medical College</name>
      <address>
        <city>Bengbu</city>
        <state>Anhui</state>
        <zip>233004</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Second People's Hospital of Hefei</name>
      <address>
        <city>Hefei</city>
        <state>Anhui</state>
        <zip>230011</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Second Hospital of Anhui Medical University</name>
      <address>
        <city>Hefei</city>
        <state>Anhui</state>
        <zip>230601</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chongqing People's Hospital</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <zip>400013</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Guangzhou First People's Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Guangdong Provincial People's Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Guangzhou Medical University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510120</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Qingyuan People's Hospital</name>
      <address>
        <city>Qingyuan</city>
        <state>Guangdong</state>
        <zip>511500</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zhongnan Hospital of Wuhan University</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430071</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Second Xiangya Hospital of Central South University</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410008</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nanjing First Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zibo Central Hospital</name>
      <address>
        <city>Zibo</city>
        <state>Shandong</state>
        <zip>255036</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West China Hospital, Sichuan University</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610065</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Huashan Hospital Affiliated Fudan University</name>
      <address>
        <city>Shanghai</city>
        <zip>200040</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shanghai Pulmonary Hospital</name>
      <address>
        <city>Shanghai</city>
        <zip>200433</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences</name>
      <address>
        <city>Tianjin</city>
        <zip>300020</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>General Hospital of Tianjin Medical University</name>
      <address>
        <city>Tianjin</city>
        <zip>300052</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CEQUIN Foundation Cardiomet</name>
      <address>
        <city>Armenia</city>
        <zip>630002</zip>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>De La Costa Clinic Ltd.</name>
      <address>
        <city>Barranquilla</city>
        <zip>080020</zip>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University IPS - Leon XIII Clinic</name>
      <address>
        <city>Medellín</city>
        <zip>050012</zip>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Amiens Picardie University Hospital - South</name>
      <address>
        <city>Amiens</city>
        <zip>80480</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Victor Dupouy - Argenteuil</name>
      <address>
        <city>Argenteuil</city>
        <zip>95107</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Roger Salengro Hospital</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marseille University Hospital Center - North Hospital</name>
      <address>
        <city>Marseille</city>
        <zip>13015</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hotel Dieu Hospital Nantes University Hospital Center</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint-Louis Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75475</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Paris University Hospitals Center - Cochin Hospital</name>
      <address>
        <city>Paris</city>
        <zip>95107</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Center of Poitiers</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Civil Hospital of Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tours University Hospital Center, Bretonneau Hospital</name>
      <address>
        <city>Tours</city>
        <zip>37000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Köln</name>
      <address>
        <city>Cologne</city>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Freiburg</name>
      <address>
        <city>Freiburg</city>
        <zip>79106</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Johannes Gutenberg University Medical Center</name>
      <address>
        <city>Mainz</city>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>General Hospital of Athens &quot;Evangelismos&quot;, 5th Department of Internal Medicine and Infectious Diseases Unit</name>
      <address>
        <city>Athens</city>
        <zip>10676</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>General Hospital of Athens &quot;Evangelismos&quot;</name>
      <address>
        <city>Athens</city>
        <zip>10676</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>General Hospital of Athens &quot;Laikon&quot;, Infectious Diseases Unit</name>
      <address>
        <city>Athens</city>
        <zip>11527</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>General Hospital of Athens &quot;Laikon&quot;</name>
      <address>
        <city>Athens</city>
        <zip>11527</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>General Hospital of Thessaloniki Ippokratio</name>
      <address>
        <city>Thessaloníki</city>
        <zip>54642</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bnai Zion Medical Center</name>
      <address>
        <city>Haifa</city>
        <zip>3339419</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lady Davis Carmel Medical Center</name>
      <address>
        <city>Haifa</city>
        <zip>3436212</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rambam Health Care Campus</name>
      <address>
        <city>Haifa</city>
        <zip>35254</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Edith Wolfson Medical Center</name>
      <address>
        <city>H̱olon</city>
        <zip>5822012</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hadassah Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <zip>9112001</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Baruch Padeh Medical Center</name>
      <address>
        <city>Nazareth</city>
        <zip>16100</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ziv Medical Center</name>
      <address>
        <city>Safed</city>
        <zip>1311001</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Tel Aviv Sourasky Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <zip>6423906</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chaim Sheba Medical Center</name>
      <address>
        <city>Tel Hashomer</city>
        <zip>5262000</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Polyclinic S. Orsola-Malpighi, Dept. of Organ Impairment and Transplants</name>
      <address>
        <city>Bologna</city>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Large Metropolitan Hospital Niguarda, Infectious Diseases Department</name>
      <address>
        <city>Milan</city>
        <zip>20161</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Polyclinic Hospital of Modena</name>
      <address>
        <city>Modena</city>
        <zip>41124</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Modena</name>
      <address>
        <city>Modena</city>
        <zip>71-41124</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Milano-Bicocca - San Gerardo Hospital</name>
      <address>
        <city>Monza</city>
        <zip>20900</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Polyclinic Hospital &quot;Paolo Giaccone&quot; Palermo, Infectious Disease Department, ICU</name>
      <address>
        <city>Palermo</city>
        <zip>90127</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Polyclinic Foundation Agostino Gemelli - IRCCS</name>
      <address>
        <city>Rome</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Integrated University Health Authority of Trieste</name>
      <address>
        <city>Trieste</city>
        <zip>34125</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Integrated University Hospital &quot;Santa Maria della Misericordia&quot; of Udine</name>
      <address>
        <city>Udine</city>
        <zip>22100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wonju Severance Christian Hospital</name>
      <address>
        <city>Wŏnju</city>
        <state>Gangwon-do</state>
        <zip>26426</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dong-A University Hospital</name>
      <address>
        <city>Busan</city>
        <zip>49201</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Severance Hospital, Yonsei University Health System</name>
      <address>
        <city>Seoul</city>
        <zip>03722</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>06351</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chung-Ang University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>06793</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ajou University Hospital</name>
      <address>
        <city>Suwon</city>
        <zip>16499</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National University Hospital</name>
      <address>
        <city>Singapore</city>
        <zip>119074</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tan Tock Seng Hospital</name>
      <address>
        <city>Singapore</city>
        <zip>119074</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Germans Trias i Pujol</name>
      <address>
        <city>Badalona</city>
        <zip>08916</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Cruces</name>
      <address>
        <city>Baracaldo</city>
        <zip>48903</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital del Mar, Department of Infectious Diseases</name>
      <address>
        <city>Barcelona</city>
        <zip>08003</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Vall d'Hebron (HUVH)</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic of Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Parc Tauli Health Corporation</name>
      <address>
        <city>Barcelona</city>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>General University Hospital Gregorio Maranon</name>
      <address>
        <city>Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Ramon y Cajal</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Clinical San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>La Paz University Hospital</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Puerta de Hierro Majadahonda</name>
      <address>
        <city>Majadahonda</city>
        <zip>28220</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Virgen Macarena</name>
      <address>
        <city>Sevilla</city>
        <zip>41009</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University and Polytechnic Hospital La Fe</name>
      <address>
        <city>Valencia</city>
        <zip>46026</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaohsiung Medical University Chung-Ho Memorial Hospital</name>
      <address>
        <city>Kaohsiung</city>
        <zip>80756</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>China Medical University Hospital</name>
      <address>
        <city>Taichung</city>
        <zip>40447</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>10002</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Taipei Veterans General Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>11217</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Linkou Chang Gung Memorial Hospital</name>
      <address>
        <city>Taoyuan City</city>
        <zip>333</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>King Chulalongkorn Memorial Hospital</name>
      <address>
        <city>Bangkok</city>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rajavithi Hospital</name>
      <address>
        <city>Bangkok</city>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ramathibodi Hospital</name>
      <address>
        <city>Bangkok</city>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Siriraj Hospital</name>
      <address>
        <city>Bangkok</city>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maharaj Nakorn Chiang Mai Hospital</name>
      <address>
        <city>Chiang Mai</city>
        <zip>50200</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Srinagarind Hospital</name>
      <address>
        <city>Khon Kaen</city>
        <zip>40002</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Thammasat University Hospital</name>
      <address>
        <city>Pathum Thani</city>
        <zip>12120</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Songklanagarind Hospital</name>
      <address>
        <city>Songkhla</city>
        <zip>90110</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hacettepe University School of Medicine</name>
      <address>
        <city>Ankara</city>
        <zip>06100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ankara University School of Medicine</name>
      <address>
        <city>Ankara</city>
        <zip>06230</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Istanbul University School of Medicine</name>
      <address>
        <city>Istanbul</city>
        <zip>34093</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marmara University Pendik Training and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34899</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medipol Mega University Hospital</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Australia</country>
    <country>Belgium</country>
    <country>Bulgaria</country>
    <country>China</country>
    <country>Colombia</country>
    <country>France</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Korea, Republic of</country>
    <country>Singapore</country>
    <country>Spain</country>
    <country>Taiwan</country>
    <country>Thailand</country>
    <country>Turkey</country>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 30, 2018</study_first_submitted>
  <study_first_submitted_qc>September 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 12, 2018</study_first_posted>
  <last_update_submitted>August 17, 2021</last_update_submitted>
  <last_update_submitted_qc>August 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Mycoses</keyword>
  <keyword>Candidiasis</keyword>
  <keyword>Candidiasis, Invasive</keyword>
  <keyword>Candidemia</keyword>
  <keyword>Fungemia</keyword>
  <keyword>Sepsis</keyword>
  <keyword>Invasive Fungal Infections</keyword>
  <keyword>Systemic Inflammatory Response Syndrome</keyword>
  <keyword>Pathologic Processes</keyword>
  <keyword>Fluconazole</keyword>
  <keyword>Caspofungin</keyword>
  <keyword>Echinocandins</keyword>
  <keyword>Antifungal Agents</keyword>
  <keyword>Anti-infective Agents</keyword>
  <keyword>14-alpha Demethylase Inhibitors</keyword>
  <keyword>Cytochrome P-450 Enzyme Inhibitors</keyword>
  <keyword>Enzyme Inhibitors</keyword>
  <keyword>Molecular Mechanisms of Pharmacological Action</keyword>
  <keyword>Steroid Synthesis Inhibitors</keyword>
  <keyword>Physiological Effects of Drugs</keyword>
  <keyword>Cytochrome P-450 CYP2C9 Inhibitors</keyword>
  <keyword>Cytochrome P-450 CYP2C19 Inhibitors</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mycoses</mesh_term>
    <mesh_term>Candidiasis</mesh_term>
    <mesh_term>Candidemia</mesh_term>
    <mesh_term>Candidiasis, Invasive</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluconazole</mesh_term>
    <mesh_term>Caspofungin</mesh_term>
    <mesh_term>Rezafungin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

